Negative Regulation of TLR Inflammatory Signaling by the SUMO-deconjugating Enzyme SENP6

PLoS Pathogens

Volumn 9, Issue 6, 2013, Pages

  Liu, Xing ^a   Chen, Wei ^a   Wang, Qiang ^a   Li, Li ^a   Wang, Chen ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; PEPTIDES AND PROTEINS; SMALL INTERFERING RNA; SUMO 2 PROTEIN; SUMO 3 PROTEIN; SUMO SPECIFIC PROTEASE 6; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE; CELL ISOLATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INFLAMMATION; KUPFFER CELL; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SUMOYLATION;

ANIMALS; CELL LINE; CYSTEINE ENDOPEPTIDASES; ENDOTOXINS; HUMANS; I-KAPPA B KINASE; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; SEPSIS; SIGNAL TRANSDUCTION; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMOYLATION; TOLL-LIKE RECEPTORS; UBIQUITINS;

MUS;

EID: 84879546850     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003480     Document Type: Article

References (44)

1. Kawai T, Akira S, (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373-384.
2. Medzhitov R, (2007) Recognition of microorganisms and activation of the immune response. Nature 449: 819-826.
3. Cook DN, Pisetsky DS, Schwartz DA, (2004) Toll-like receptors in the pathogenesis of human disease. Nat Immunol 5: 975-979.
4. Beutler B, (2004) Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430: 257-263.
5. Akira S, Takeda K, (2004) Toll-like receptor signalling. Nat Rev Immunol 4: 499-511.
6. Karin M, (1999) How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 18: 6867-6874.
7. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M, (1997) The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91: 243-252.
8. Israel A, (2000) The IKK complex: an integrator of all signals that activate NF-kappa B? Trends in Cell Biology 10: 129-133.
9. Rothwarf DM, Zandi E, Natoli G, Karin M, (1998) IKK-gamma is an essential regulatory subunit of the I kappa B kinase complex. Nature 395: 297-300.
10. Wu CJ, Conze DB, Li T, Srinivasula SM, Ashwell JD, (2006) NEMO is a sensor of Lys 63-linked polyubiquitination and functions in NF-kappa B activation. Nature Cell Biology 8: 398-U358.
11. Laplantine E, Fontan E, Chiaravalli J, Lopez T, Lakisic G, et al. (2009) NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain. Embo Journal 28: 2885-2895.
12. Tang ED, Wang CY, Xiong Y, Guan KL, (2003) A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha. J Biol Chem 278: 37297-37305.
13. Tokunaga F, Sakata S, Saeki Y, Satomi Y, Kirisako T, et al. (2009) Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat Cell Biol 11: 123-132.
14. Kovalenko A, Chable-Bessia C, Cantarella G, Israel A, Wallach D, et al. (2003) The tumour suppressor CYLD negatively regulates NF-kappa B signalling by deubiquitination. Nature 424: 801-805.
15. Huang TT, Wuerzberger-Davis SM, Wu ZH, Miyamoto S, (2003) Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 115: 565-576.
16. Desterro JM, Rodriguez MS, Hay RT, (1998) SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 2: 233-239.
17. Israel A, (2010) The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb Perspect Biol 2: a000158.
18. Hay RT, (2005) SUMO: a history of modification. Mol Cell 18: 1-12.
19. Geiss-Friedlander R, Melchior F, (2007) Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 8: 947-956.
20. Mukhopadhyay D, Dasso M, (2007) Modification in reverse: the SUMO proteases. Trends Biochem Sci 32: 286-295.
21. Yeh ET, (2009) SUMOylation and De-SUMOylation: wrestling with life's processes. J Biol Chem 284: 8223-8227.
22. Cheng J, Kang X, Zhang S, Yeh ET, (2007) SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell 131: 584-595.
23. Chung SS, Ahn BY, Kim M, Choi HH, Park HS, et al. (2010) Control of adipogenesis by the SUMO-specific protease SENP2. Mol Cell Biol 30: 2135-2146.
24. Kang X, Qi Y, Zuo Y, Wang Q, Zou Y, et al. (2010) SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development. Mol Cell 38: 191-201.
25. Lee MH, Mabb AM, Gill GB, Yeh ET, Miyamoto S, (2011) NF-kappaB induction of the SUMO protease SENP2: A negative feedback loop to attenuate cell survival response to genotoxic stress. Mol Cell 43: 180-191.
26. May MJ, D'Acquisto F, Madge LA, Glockner J, Pober JS, et al. (2000) Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 289: 1550-1554.
27. Dou H, Huang C, Singh M, Carpenter PB, Yeh ET, (2010) Regulation of DNA Repair through DeSUMOylation and SUMOylation of Replication Protein A Complex. Mol Cell 39: 333-345.
28. Shi M, Deng W, Bi E, Mao K, Ji Y, et al. (2008) TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation. Nat Immunol 9: 369-377.
29. Wertz IE, Dixit VM, (2010) Signaling to NF-kappaB: regulation by ubiquitination. Cold Spring Harb Perspect Biol 2: a003350.
30. Liu S, Chen ZJ, (2011) Expanding role of ubiquitination in NF-kappaB signaling. Cell Res 21: 6-21.
31. Wertz IE, O'Rourke KM, Zhou HL, Eby M, Aravind L, et al. (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappa B signalling. Nature 430: 694-699.
32. Enesa K, Zakkar M, Chaudhury H, Luong LA, Rawlinson L, et al. (2008) NF-kappa B suppression by the deubiquitinating enzyme Cezanne- A novel negative feedback loop in pro-inflammatory signaling. Journal of Biological Chemistry 283: 7036-7045.
33. Zhou HL, Monack DM, Kayagaki N, Wertz I, Yin JP, et al. (2005) Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-kappa B activation. Journal of Experimental Medicine 202: 1327-1332.
34. Li S, Zheng H, Mao AP, Zhong B, Li Y, et al. (2010) Regulation of virus-triggered signaling by OTUB1- and OTUB2-mediated deubiquitination of TRAF3 and TRAF6. J Biol Chem 285: 4291-4297.
35. Sun SC, (2008) Deubiquitylation and regulation of the immune response. Nat Rev Immunol 8: 501-511.
36. Renner F, Saul VV, Pagenstecher A, Wittwer T, Schmitz ML, (2011) Inducible SUMO modification of TANK alleviates its repression of TLR7 signalling. EMBO Rep 12: 129-135.
37. Chang TH, Xu S, Tailor P, Kanno T, Ozato K, (2012) The small ubiquitin-like modifier-deconjugating enzyme sentrin-specific peptidase 1 switches IFN regulatory factor 8 from a repressor to an activator during macrophage activation. J Immunol 189: 3548-3556.
38. Ran Y, Liu TT, Zhou Q, Li S, Mao AP, et al. (2011) SENP2 negatively regulates cellular antiviral response by deSUMOylating IRF3 and conditioning it for ubiquitination and degradation. J Mol Cell Biol 3: 283-292.
39. Kim KI, Baek SH, Jeon YJ, Nishimori S, Suzuki T, et al. (2000) A new SUMO-1-specific protease, SUSP1, that is highly expressed in reproductive organs. J Biol Chem 275: 14102-14106.
40. Lou XW, Sun SG, Chen W, Zhou Y, Huang YF, et al. (2011) Negative Feedback Regulation of NF-kappa B Action by CITED2 in the Nucleus. Journal of Immunology 186: 539-548.
41. Shi HX, Liu X, Wang Q, Tang PP, Liu XY, et al. (2011) Mitochondrial ubiquitin ligase MARCH5 promotes TLR7 signaling by attenuating TANK action. PLoS Pathog 7: e1002057.
42. van Zijl F, Mair M, Csiszar A, Schneller D, Zulehner G, et al. (2009) Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. Oncogene 28: 4022-4033.
43. Su GL, Klein RD, Aminlari A, Zhang HY, Steinstraesser L, et al. (2000) Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4. Hepatology 31: 932-936.
44. Carey KD, Garton AJ, Romero MS, Kahler J, Thomson S, et al. (2006) Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib. Cancer Res 66: 8163-8171.